Knowlee vs Nabla (2026): Multi-Vertical OS vs Clinical Agentic Platform

Quick verdict. Nabla (nabla.com) is a Paris-founded clinical AI platform — started as ambient documentation, now a full agentic layer for clinical workflows: linking patient records, scheduling follow-ups, executing coding steps autonomously. $120M total raised, including a $70M Series C in June 2025 (HV Capital lead), deployed in 130+ US health systems with 85,000+ clinicians. Advisors include Yann LeCun and Tony Fadell; founder Alexandre Lebrun built Wit.ai (acquired by Facebook/Meta) and led FAIR. If the use case is clinical workflow automation at scale in the US healthcare market, Nabla is one of the most credible options in the world. Knowlee is an agentic operating system where healthcare is one of many tenants — clinical workflows sit on the same Brain and governance layer as RevOps, talent, compliance, and ops. Different scope, different buyer, different infrastructure bet.

What each platform actually is

Nabla's evolution tells the story: it started as ambient documentation (AI transcribes and structures clinical notes in real time during patient encounters), then expanded into proactive agentic actions — the system doesn't just capture; it acts. A clinical agent can link a patient record, schedule a follow-up, execute a billing code step, and flag an anomaly — all without waiting for a clinician to drive each action. The platform is exploring integration with AMI Labs world-models for deeper clinical reasoning. With 85,000+ clinicians across 130+ US health systems, Nabla has scale and deep EHR integration that no general-purpose platform can match.

Knowlee is not a clinical platform. It is an agentic OS for organizations running AI agents across multiple business functions — sales, legal, talent, CX, ops, and healthcare among them. A hospital group using Knowlee would deploy clinical workflow agents (patient record linking, follow-up scheduling) alongside RevOps agents (payer relationship management, contract renewal tracking) and talent agents (clinician sourcing, credentialing tracking), all sharing a single Neo4j Brain and a single AI Act-compliant audit trail. That multi-vertical compounding is Knowlee's structural advantage. Nabla's clinical depth is Nabla's structural advantage.

Architecture difference: clinical depth vs cross-vertical breadth

Nabla: clinician-facing agentic platform

Nabla's architecture is optimized for the clinical encounter and the workflows downstream of it. The ambient documentation capability requires real-time, low-latency processing of clinical conversations and tight integration with EHR systems (Epic, Cerner, etc.). The agentic layer that acts on those captured encounters requires clinical domain knowledge — ICD coding, scheduling protocols, billing rules — that takes years to get right and requires ongoing validation as clinical standards evolve. Nabla's 85,000+ clinician deployments represent a validation asset that no general-purpose platform has replicated.

The constraint is vertical specificity: Nabla is designed for the clinical encounter and its immediate downstream workflows. It is not designed to also run the health system's payer-contracting outreach, the physician recruitment pipeline, or the compliance reporting workflow.

Knowlee: multi-vertical Brain with healthcare as one tenant

Knowlee's architecture routes all agent outputs through the same Neo4j Brain. A healthcare tenant's clinical agents share that Brain with RevOps agents, talent agents, and compliance agents. A patient readmission signal picked up by a clinical agent is visible to the care management team's outreach agent. A payer contract renewal deadline tracked by the RevOps agent is visible to the clinical operations team's scheduling agent. That cross-function compounding is the value proposition — and it requires a general-purpose OS, not a clinical-specific platform.

Side-by-side comparison

Where Nabla wins

• Clinical depth. EHR integration at 130+ US health systems, real-time ambient transcription, ICD coding, scheduling protocols — Nabla has invested years in the clinical domain. No general-purpose OS replicates that depth.
• Clinician trust and adoption. 85,000+ active clinician users is a validation signal that requires years to accumulate. The ambient documentation use case has demonstrated value at scale.
• World-class advisors. Yann LeCun and Tony Fadell bring AI research and hardware/product credibility that is relevant for clinical AI conversations.
• US market penetration. For a health system operating primarily in the US, Nabla's EHR partnerships and clinical workflow integrations are already in place. Starting from a general-purpose OS means rebuilding those integrations.
• Founder pedigree. Alexandre Lebrun built Wit.ai and led FAIR — that technical credibility matters for clinical AI procurement conversations.

Where Knowlee wins

• Multi-function automation. A health system that needs to automate payer contracting, physician recruitment, compliance reporting, and clinical workflows simultaneously cannot do all of that on Nabla. Knowlee covers the full range.
• Cross-vertical compounding. Patient signals feeding care management outreach, payer contract signals feeding clinical operations planning — that cross-function compounding requires a shared Brain. Nabla keeps clinical signals inside the clinical layer.
• EU AI Act native compliance. Knowlee's per-job governance metadata is designed for EU AI Act audits. For EU-based health systems, that native compliance architecture is a meaningful differentiator.
• Operator-grade fleet visibility. The kanban runtime gives a single ops leader visibility across every running agent — clinical, administrative, and commercial. A clinical-specific dashboard cannot provide that picture.
• RevOps and talent alongside clinical. A hospital group's payer relationship management, physician sourcing, and clinical operations are all business functions that benefit from agentic automation. Knowlee covers all of them; Nabla covers one.

Decision framework

You are a US health system or hospital group. Clinical workflow automation is the primary use case. EHR integration, ambient documentation, and clinical coding are table stakes. Cross-functional automation is a future consideration. → Nabla is the right platform for the clinical layer. The depth, the deployment scale, and the advisory credibility are real.

You are a European health system. EU AI Act compliance is a requirement. Multi-function automation — clinical alongside RevOps, talent, and compliance — is in scope. → Knowlee's native EU governance architecture and multi-vertical OS are the right fit. Nabla's US-market depth has not translated to equivalent EU positioning.

You are a health-adjacent organization (pharma, medical device, health insurance) automating multiple functions. Clinical workflow is one automation; sales, legal, and HR are others. You need a shared Brain and a single audit trail. → Knowlee. Nabla is optimized for the clinical encounter inside a health system; it is not designed for cross-function automation at a health-adjacent enterprise.

For the broader multi-vertical OS picture, see Knowlee vs CrewAI and agentic OS vs agent platform. For EU healthcare compliance context, see agentic operating system and multi-agent orchestration.

Book a 20-minute deployment review | See the platform | Compare with Almawave